Viracta, a California biotech oncology firm, is laying off every remaining employee and shutting down after its cash stores ...
To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...
A collaboration between Abertay University and a food biotechnology company has led to the development of an innovative ...
The research got the thrust after the Department of Biotechnology (DBT), Ministry of Science and Technology and Indian Space ...
Some 4,000 biotech industry businesses employ about 40,000 workers at well-above-average wages, with ripple effects across ...
The government of Mexico on Thursday rescinded its ban on U.S. biotech (GE, or genetically engineered) corn. “Mexico’s action ...
The small, Ireland-based company GH Research said its inhaled version of mebufotenin — a molecular cousin to psilocybin — was ...
NKGen Biotech (NKGN) announced that the U.S. Food and Drug Administration, FDA, has granted Fast Track designation, FTD, for the investigation ...
10d
Stockhead on MSNDr Boreham’s Crucible: FDA approval blasted this regenerative biotech higher in 2024… so what’s next?Fresh from FDA approval for its paediatric stem-cell product, Mesoblast is pursuing consent for indications of heart disease ...
HOUSTON - Moleculin Biotech, Inc. (NASDAQ:MBRX), a pharmaceutical company specializing in treatments for tumors and viruses, has initiated the exercise of existing warrants which is expected to ...
The biotechnology trade journal Fierce Biotech ... marked by the first FDA (U.S. Food and Drug Administration) approval of our internally developed product, Zanidatamab, significant clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results